Literature DB >> 10229205

Analysis of native WT1 protein from frozen human kidney and Wilms' tumors.

S Iben1, B Royer-Pokora.   

Abstract

The Wilms' tumor susceptibility gene, WT1, is altered in a subset of Wilms' tumors and encodes a transcription factor with four zinc fingers. Here we describe the isolation of native WT1 protein from frozen normal human kidney and Wilms' tumor samples. Through size exclusion chromatography and Western blot analysis we determined the elution pattern of WT1. The majority of WT1 from adult kidney and Wilms' tumor specimens was found to elute at a size of approximately 120 kDa, consistent with a WT1 homodimer and some WT1 protein was also found in a higher molecular weight complex. In 14 week fetal kidney the majority of the WT1 protein eluted at a size of 80 kDa, suggesting that at this developmental stage the WT1 protein is not present as a homodimer. The identity of complexing partners can now be studied using this approach.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10229205     DOI: 10.1038/sj.onc.1202618

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  7 in total

1.  Par4 is a coactivator for a splice isoform-specific transcriptional activation domain in WT1.

Authors:  D J Richard; V Schumacher; B Royer-Pokora; S G Roberts
Journal:  Genes Dev       Date:  2001-02-01       Impact factor: 11.361

2.  Classification of a frameshift/extended and a stop mutation in WT1 as gain-of-function mutations that activate cell cycle genes and promote Wilms tumour cell proliferation.

Authors:  Maike Busch; Heinrich Schwindt; Artur Brandt; Manfred Beier; Nicole Görldt; Paul Romaniuk; Eneda Toska; Stefan Roberts; Hans-Dieter Royer; Brigitte Royer-Pokora
Journal:  Hum Mol Genet       Date:  2014-03-11       Impact factor: 6.150

3.  AHR regulates WT1 genetic programming during murine nephrogenesis.

Authors:  M Hadi Falahatpisheh; Adrian Nanez; Kenneth S Ramos
Journal:  Mol Med       Date:  2011-08-18       Impact factor: 6.354

4.  HtrA2, taming the oncogenic activities of WT1.

Authors:  Jörg Hartkamp; Stefan G E Roberts
Journal:  Cell Cycle       Date:  2010-07-01       Impact factor: 4.534

5.  A mutant Ahr allele protects the embryonic kidney from hydrocarbon-induced deficits in fetal programming.

Authors:  Adrian Nanez; Irma N Ramos; Kenneth S Ramos
Journal:  Environ Health Perspect       Date:  2011-07-29       Impact factor: 9.031

6.  Identification of a Novel C-Terminal Truncated WT1 Isoform with Antagonistic Effects against Major WT1 Isoforms.

Authors:  Naoya Tatsumi; Nozomi Hojo; Hiroyuki Sakamoto; Rena Inaba; Nahoko Moriguchi; Keiko Matsuno; Mari Fukuda; Akihide Matsumura; Seiji Hayashi; Soyoko Morimoto; Jun Nakata; Fumihiro Fujiki; Sumiyuki Nishida; Hiroko Nakajima; Akihiro Tsuboi; Yoshihiro Oka; Naoki Hosen; Haruo Sugiyama; Yusuke Oji
Journal:  PLoS One       Date:  2015-06-19       Impact factor: 3.240

7.  BASP1 is a transcriptional cosuppressor for the Wilms' tumor suppressor protein WT1.

Authors:  Brian Carpenter; Kathryn J Hill; Marika Charalambous; Kate J Wagner; Diya Lahiri; Dominic I James; Jens S Andersen; Valérie Schumacher; Brigitte Royer-Pokora; Matthias Mann; Andrew Ward; Stefan G E Roberts
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.